Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

    May 26, 2023

    India as a Quad-led biomanufacturing hub

    May 25, 2023

    Manappuram Finance, Rossari Biotech shares trade ex-dividend today

    May 24, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

      May 26, 2023

      India as a Quad-led biomanufacturing hub

      May 25, 2023

      Manappuram Finance, Rossari Biotech shares trade ex-dividend today

      May 24, 2023

      Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

      May 23, 2023

      Israeli biotech phenom puts death knell on cancer

      May 22, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Pharmaceutical»Junk’ DNA may hold the key to neurological disorders
    Pharmaceutical

    Junk’ DNA may hold the key to neurological disorders

    yourbiotechBy yourbiotechOctober 2, 2022Updated:November 11, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    University of Lincoln and the University of Sheffield are researching how DNA could be repaired

    New research has found that there is a link between non-coding DNA and certain neurological disorders such as Alzheimer’s and motor neurone disease.

    A team from the University of Lincoln and the University of Sheffield identified how oxidative breaks in so-called ‘junk’ DNA are formed and repaired, exploring how the repairing of these breaks could protect us from neurological diseases in the future.

    The discovery unlocks the potential for pioneering new research into this ‘junk’ DNA, which makes up 98% of our total cellular DNA.

    Lead author, Dr Swagat Ray, senior lecturer in cell biology at the School of Life and Environmental Sciences at the University of Lincoln, explained: “This is the culmination of half a decade of rigorous research by an exceptionally talented team led by Professor Sherif El-Khamisy at the University of Sheffield”.

    “Oxidative stress is an unavoidable consequence of cellular metabolism and can be influenced by factors such as diet, lifestyle and environment. In the long term, oxidative stress can cause irreparable damage to the body’s cells, proteins and DNA, accelerating the ageing process and contributing to the development of neurological diseases such as dementia,” he added.

    Up to one billion people all over the world suffer from neurological conditions such as motor neurone disease and Alzheimer’s, which are caused by the progressive loss of brain cells called neurones.

    The findings of this study can now pave the way for future research, which could lead to earlier detection, delay or even curing many neurological disorders.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleIRCTC, Ashok Leyland, GSK Pharma and more: Top stock tips by Mitessh Thakkar, Sudarshan Sukhani
    Next Article Biden to Announce New Support for US Biotech Production
    yourbiotech
    • Website

    Related Posts

    Pharma company owner duped of ₹1.1 crore

    November 11, 2022

    Novavax cuts full-year revenue forecast again amid weak demand

    November 10, 2022

    Aurobindo units recall products in US market for manufacturing issues

    November 9, 2022

    AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

    November 8, 2022

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.